The Sinuva implant is a steroid-eluting bioabsorbable sinus implant intended to be placed in the ethmoid sinuses during a physician office visit. It is proposed as a less invasive alternative to revision sinus surgery in patients with recurrent sinus polyps after sinus surgery. The Sinuva implant is composed of a bioabsorbable polymer and has a self-expanding, nonobstructive design; the implant releases mometasone furoate, an anti-imflammatory steroid, directly into the sinus lining over approximately 90 days.

If you have a Hayes login, click here to view the full report on the Knowledge Center.